Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy.
- DOI
- 10.1016/j.jconrel.2026.115460
- Published
- 2026 Oct 16
- Container
- Journal of controlled release : official journal of the Controlled Release Society
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jconrel.2026.115460,
title = {Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy.},
author = {Wang T and Wang L and Kang X and Jiang J and Yuan B and Zhang L and Yu X and Chen T and Li X and Zhang Y and Meng W and Li J and Qi J and Ding D and Shi Y and Li W},
year = {2026},
journal = {Journal of controlled release : official journal of the Controlled Release Society},
doi = {10.1016/j.jconrel.2026.115460},
url = {https://doi.org/10.1016/j.jconrel.2026.115460}
}RIS
TY - JOUR TI - Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy. AU - Wang T AU - Wang L AU - Kang X AU - Jiang J AU - Yuan B AU - Zhang L AU - Yu X AU - Chen T AU - Li X AU - Zhang Y AU - Meng W AU - Li J AU - Qi J AU - Ding D AU - Shi Y AU - Li W PY - 2026 JO - Journal of controlled release : official journal of the Controlled Release Society DO - 10.1016/j.jconrel.2026.115460 UR - https://doi.org/10.1016/j.jconrel.2026.115460 ER -
APA
T, W., L, W., X, K., J, J., B, Y., L, Z., X, Y., T, C., X, L., Y, Z., W, M., J, L., J, Q., D, D., Y, S., & W, L. (2026). Annexin A5-engineered nanovaccines synchronize spatiotemporal antigen release with phagocytosis checkpoint blockade for potent in situ cancer immunotherapy.. Journal of controlled release : official journal of the Controlled Release Society. https://doi.org/10.1016/j.jconrel.2026.115460
Source records
- pubmed · retrieved 2026-11-10T11:41:28.540Z